Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 4 August 2009, doi:10.1136/bmj.b3145
Cite this as: BMJ 2009;339:b3145
| The first 100% of the full text of this article appears below. |
That drugs for Parkinsons disease should be reconsidered, stopped, or reduced in managing older people during heat waves needs to be challenged.1
Missed (or even reduced) doses of dopaminergic agents such as levodopa or dopamine agonists have been associated with the potentially life threatening condition neuroleptic malignant-like syndrome.2 3 This condition, which is associated with confusion, rigidity, fever, and raised muscle enzyme activities, is more likely in dehydrated people and during hot weather.4
The advice should be for patients to continue their usual treatment (unless advised by a movement disorder specialist that they are being overtreated) and focus on ensuring adequate hydration. Any other approach could undermine the important message that patients with Parkinsons disease require the correct treatment every time.5
Cite this as: BMJ 2009;339:b3145
Richard W Genever, consultant geriatrician and movement disorders lead1
1 Chesterfield Royal Hospital NHS Foundation Trust, Chesterfield S44 5BL
richard.genever@chesterfieldroyal.nhs.uk